Find your next paid study

Children's Mercy Hospital Kansas CityNCT07657195

Actual pay is set by the research site.

Observational

Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach

Variable outcomes after weight loss surgery are likely attributable to complex, poorly understood mechanisms. Due to the significant impact that morbid obesity…

Obesity, MorbidMetabolic SyndromeNASH - Nonalcoholic Steatohepatitis

University of Missouri-ColumbiaNCT04841057

Actual pay is set by the research site.

X-linked Severe Combined Immunodeficiency (XSCID)

Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency

This is a Phase I/II non-randomized clinical trial of ex vivo hematopoietic stem cell (HSC) gene transfer treatment for X-linked severe combined immunodeficien…

National Institute of Allergy and Infectious Diseases (NIAID)NCT01306019

~$150 – $2,700

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Double-blind, Study of Belzutifan + Zanzalintinib Versus Belzutifan + Placebo in Participants With Advanced RCC Who Have Progressed on or After Both PD-1/L1 and VEGF-TKI Therapies in Sequence or in Combination (LITESPARK-034)

Researchers are looking for new ways to treat advanced renal cell carcinoma (RCC). A standard (usual) treatment for certain people with RCC is belzutifan (a s…

Carcinoma, Renal Cell

Merck Sharp & Dohme LLCNCT07489495

~$50 – $2,100

Actual pay is set by the research site.

Phase 2

The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People

The investigators recently demonstrated that blockade of Glucagon-Like Peptide-1's (GLP-1) receptor (GLP1R) results in changes in islet function without change…

Type 1 DiabetesType 2 Diabetes

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT06976619

Type 1 Diabetes (T1D)Type 1 Diabetes Mellitus

POLARIS: A Phase 1, Single Dose, Open-label Study of GNTI-122 in Adults With Recently Diagnosed Type 1 Diabetes (T1D)

This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time…

ObservationalRemote eligible

~$150 – $4,200

Actual pay is set by the research site.

GentiBio, IncNCT06919354

Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

Dyspnea, or breathlessness, is one of the most common and distressing symptoms experienced by patients with advanced lung cancer. The purpose of this multi-sit…

Advanced Lung CancerDyspnea

Massachusetts General HospitalNCT06791057

Actual pay is set by the research site.

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion and Intra-Articular Injection for the Treatment of Rheumatoid Arthritis

This trial will study the safety and efficacy of intravenous infusion and intra-articular injection of cultured allogeneic adult umbilical cord or placental de…

Rheumatoid Arthritis

The Foundation for Orthopaedics and Regenerative MedicineNCT05003934

~$150 – $3,000

Actual pay is set by the research site.

A Phase 1, Single-Dose, Open-Label Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on Aleniglipron Pharmacokinetics

The purpose of this study is to evaluate the PK of aleniglipron in participants with Hepatic Impairment to establish scientifically guided dosing recommendatio…

Hepatic Impairment

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsNCT07872033

~$150 – $4,200

Actual pay is set by the research site.

Phase 2

Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer (MAPPER)

This is an exploratory phase II interventional study that initiates standard-of-care anti-estrogen treatment preoperatively for 4-12 weeks (+/- 2 weeks).

Breast Cancer

Medical College of WisconsinNCT06361940

~$75 – $2,000

Actual pay is set by the research site.

Observational

Applying a Family Caregiver Supports Needs Assessment Tool in Home-based Primary Care: An Approach to Elder Mistreatment Risk Reduction and Prevention

This study will evaluate the feasibility, acceptability, and preliminary effects of the Carer Support Needs Assessment Tool (CSNAT) intervention for family car…

Caregiver StressCaregiver Health Related QOLCaregiver Mental Health+3 more

The University of Texas Medical Branch, GalvestonNCT07749482

Actual pay is set by the research site.

A Two-Part Open-Label Study of REGV131-LNP1265, A CRISPR/Cas9 Based Coagulation Factor IX Gene Insertion Therapy in Participants With Hemophilia B

Participants in this study have a genetic mutation, specifically in the coagulation (blood clotting) Factor 9 gene that causes severe or moderately severe hemo…

Hemophilia B